Dr. Rick C. Sasso, famend spinal surgeon to spotlight Surgalign’s HOLO Portal™ Surgical Steering System on the OrthoDome Panel on March 8, 2023.
DEERFIELD, In poor health., March 03, 2023 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc. (Nasdaq: SRGA), a worldwide medical know-how firm centered on elevating the usual of care by driving the evolution of digital surgical procedure, at the moment introduced its participation on the 2023 American Academy of Orthopaedic Surgeons (“AAOS”) Annual Assembly, which is able to happen March 7-11, 2023 in Las Vegas, Nevada.
Over this five-day occasion, business will collect to debate the most recent evidence-based developments which can be reworking the best way medical professionals care for his or her sufferers. The Firm is a collaborating sponsor of OrthoDome, an AAOS Annual Assembly expertise that provides an immersive and comfy video theater room showcasing orthopaedic surgical methods and units in 4K decision video, narrated by reside specialists and chaired by Ronald A. Navarro, MD, FAAOS and Lisa Okay. Cannada, MD, FAAOS. On Wednesday, March 8, 2023, Dr. Vacarro will average the Backbone Panel – OrthoDome session HT01 – happening from 8:00 a.m. – 9:30 a.m. PT. This panel will embrace reside discussions and video demonstrations from main spine surgeons together with:
Barrett I. Woods, MD, FAAOS
David Kate, MD
Jose A. Canseco, MD, PhD
Victor W. Hsu, MD, FAAOS
Rick C. Sasso, MD, FAAOS
Rick Sasso, MD, is a founding member and the president of Indiana Backbone Group, the primary apply to make the most of the Firm’s HOLO Portal Surgical Steering System following receipt of U.S. Food & Drug Administration (“FDA”) 510(okay). Dr. Sasso is a board-certified orthopaedic surgeon, specializing in spine surgical procedure. He’s additionally a professor and chief of spine surgical procedure on the Indiana College Faculty of Medication, Division of Orthopaedic Surgical procedure. Dr. Sasso will current “AI by way of the Continuum of Care”, which options Surgalign’s HOLO AI and HOLO Portal applied sciences as utilized to diagnostic imaging, intra-operative surgical steering, and inhabitants analytics.
Terry Wealthy, President and CEO of Surgalign, commented, “AAOS continues to assist business advance applied sciences and enhance affected person care, and we’re particularly excited for this 12 months’s occasion, given the concentrate on spine care and the most effective applied sciences that drive higher affected person outcomes. We are able to’t thank Dr. Sasso and his workforce sufficient for his or her assist as we work to commercialize HOLO Portal and leverage our HOLO AI platform to broaden using AI and AR within the medical subject.”
With FDA clearance, HOLO Portal turned the world’s first surgical steering system to include synthetic intelligence (“AI”) and augmented actuality (“AR”). The primary process was carried out at Indiana Backbone Hospital in Carmel, Indiana and since, over 30 instances have been carried out. The HOLO Portal system’s AI processes intraoperative photos to autonomously section and label the anatomy and plan patient-specific pedicle screw trajectories which can be authorised by the surgeon. The system makes use of AR to overlay the segmented AI reconstruction over the affected person’s precise anatomy, offering real-time 3D visualization all through the surgical process, serving to surgeons visualize trajectories, whereas guiding surgical devices.
To study extra about Surgalign’s Digital Health and HOLO AI Expertise, please go to us on-line at: https://surgalign.com/digital-health/.
About Surgalign Holdings, Inc. Surgalign Holdings, Inc. is a worldwide medical know-how firm dedicated to the promise of digital well being to drive transformation throughout the surgical panorama. Uniquely aligned and resourced to advance the usual of care, the corporate is constructing applied sciences physicians and different well being suppliers will look to for what is actually potential for his or her sufferers. Surgalign is concentrated on creating options that predictably ship superior scientific and financial outcomes. Surgalign markets merchandise all through the USA and in roughly 50 nations worldwide by way of an increasing community of high unbiased distributors. Surgalign is headquartered in Deerfield, IL, with business, innovation and design facilities in San Diego, CA, Warsaw and Poznan, Poland, and Wurmlingen, Germany. Study extra at www.surgalign.com and join on LinkedIn, Twitter and Instagram.
Ahead Trying Statements This press launch incorporates forward-looking statements together with, with out limitation, statements relating the meant use of proceeds from the registered direct providing. These forward-looking statements are based mostly on administration’s present expectations, estimates and projections about our business, our administration’s beliefs and sure assumptions made by our administration. Phrases comparable to “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” variations of such phrases and comparable expressions are meant to establish such forward-looking statements. Elements that would trigger precise outcomes to vary materially from these forward-looking statements embrace: (i) the Firm’s entry to enough working money stream, commerce credit score, borrowed funds and fairness capital to fund its operations and pay its obligations as they change into due, and the phrases on which exterior financing could also be accessible, together with the affect of opposed developments or disruption within the international credit score and fairness markets; (ii) dangers referring to present or potential litigation or regulatory actions; (iii) the identification of management deficiencies, together with materials weaknesses in inner management over monetary reporting; (iv) normal worldwide financial circumstances and associated uncertainties; (v) the continued affect of the COVID-19 and the Firm’s makes an attempt at mitigation, notably in worldwide markets served by the Firm; (vi) the failure by the Firm to establish, develop and efficiently implement its strategic initiatives, notably with respect to its digital surgical procedure technique; (vii) the reliability of our provide chain; (viii) our capability to fulfill obligations, together with buy minimums, below our vendor and different agreements; (ix) whether or not or when the demand for procedures involving our merchandise will enhance; (x) our monetary place and outcomes, whole income, product income, gross margin, and operations; (xi) failure to comprehend, or sudden prices in searching for to comprehend, the anticipated advantages of the Holo Surgical Inc. (“Holo Surgical”) and Inteneural Networks Inc. (“INN”) acquisitions, together with the failure of Holo Surgical’s and INN’s services and products to be satisfactorily developed or obtain relevant regulatory approvals or because of the failure to commercialize and distribute its merchandise; (xii) the failure to successfully combine Holo Surgical’s and INN’s operations with these of the Firm, together with: retention of key personnel; the impact on relationships with prospects, suppliers, and different third events; and the diversion of administration time and a spotlight to the mixing; (xiii) the variety of shares and amount of money that can be required in reference to any post-closing milestone funds, together with because of adjustments within the buying and selling value of the Firm’s widespread inventory and their impact on the amount of money wanted by the Firm to fund any post-closing milestone funds in reference to the acquisitions; (xiv) the continuation of latest high quality points with respect to our international provide chain; and (xv) the impact and timing of adjustments in legal guidelines or in governmental laws. These components must be thought of rigorously, and undue reliance shouldn’t be positioned on the forward-looking statements. Every forward-looking assertion on this communication speaks solely as of the date of the actual assertion.
These forward-looking statements are usually not ensures of future efficiency and are topic to numerous dangers and uncertainties, together with market and different circumstances and the dangers recognized in Surgalign’s most up-to-date Annual Report on Kind 10-Okay and different filings with the SEC. Our precise outcomes might differ materially from the anticipated outcomes mirrored in these forward-looking statements. Copies of Surgalign’s SEC filings could also be obtained with out cost by visiting Surgalign’s web site at www.surgalign.com or the SEC’s web site at www.sec.gov. We undertake no obligation to replace these forward-looking statements besides as could also be required by legislation.
Investor Relations and Media Relations Contact: Glenn Wiener E-Mail: email@example.com Tel: +1 917 887 8434